Opinion: "Cuts to COVID relief programs are coming. Once again Latinos will bear the brunt of the effect"
Los Angeles Times published a commentary by Dr. Arturo Vargas Bustamante on the costs of Congressional inaction on further pandemic response funding.
![Person closing a store with a "CERRADO" sign](https://ph.ucla.edu/sites/default/files/styles/hero/public/2022-08/2022.03.25_Bustamante_LAT_Masthead.png?itok=TpqnUwg6)
Last week President Biden signed a new government spending bill into law. The roughly $22.5 billion for emergency funding for COVID-19 response efforts that the White House had requested was not included in the bill.
That was removed after congressional Republicans pushed back on spending more on COVID relief, saying they needed to better understand how the money already allocated to those efforts has been spent thus far. The cutbacks will affect, among other programs, payments to treat and vaccinate people without insurance, as well as the purchase and shipment of monoclonal antibody treatments. As has been true throughout the COVID-19 pandemic, the people likely to suffer most from these changes to COVID relief programs are communities of color, especially Latinos.
Even without the cuts to COVID spending by the government, it is important to determine what policy responses are needed federally and in California to address the health inequities Latinos and other people of color face, all of which were made worse by the pandemic. We need to prevent these injustices from reoccurring should there be a new COVID-19 surge, or in the inevitable case of a new pandemic.
Faculty Referenced by this Article
![James Macinko](https://ph.ucla.edu/sites/default/files/styles/large/public/2022-07/Macinko%2C%20J_500x500_10.jpg?itok=bsG1e-s6)
Professor of Community Health Sciences & Health Policy and Management, and Associate Dean for Research
![Michelle Keller](https://ph.ucla.edu/sites/default/files/styles/large/public/2022-07/keller-michelle_500x500.jpg?itok=uJryn-xx)
Dr. Michelle S. Keller is a health services researcher whose research focuses on the use and prescribing of high-risk medications.
![Faculty/staff profile placeholder image](https://ph.ucla.edu/sites/default/files/styles/large/public/2022-07/person-placeholder.jpg?itok=Yj28CoTl)
Dr. Ron Andersen is the Wasserman Professor Emeritus in the UCLA Departments of Health Policy and Management.
![Faculty/staff profile placeholder image](https://ph.ucla.edu/sites/default/files/styles/large/public/2022-07/person-placeholder.jpg?itok=Yj28CoTl)
EMPH Academic Program Director with expertise in healthcare marketing, finance, and reproductive health policy, teaching in the EMPH, MPH, MHA program
Nationally recognized health services researcher and sociomedical scientist with 25+ years' experience in effectiveness and implementation research.
Related Content
![Dr. Tomas J. Aragon](https://ph.ucla.edu/sites/default/files/styles/large/public/2024-05/12.29.20_AragonT_Suit.jpg?itok=aHsWRASO)
Dr. Aragón, the California State Public Health Officer, will speak at UCLA Fielding’s ceremony on June 14, 2024
Read Full Article![CHPR_2024_firearms_suiciderisk_thumbnail](https://ph.ucla.edu/sites/default/files/styles/large/public/2024-04/PastedGraphic-1_0.png?itok=S5VRCKdY)